Te­va is­sues re­call of fen­tanyl buc­cal tablets over la­bel­ing is­sue

Te­va is­sued a re­call over sev­er­al lots of its fen­tanyl buc­cal tablets used to treat can­cer pa­tients due to a la­bel­ing er­ror.

The FDA …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.